aap Implantate AG (AAQ1) - Cash Flow Conversion Efficiency

Latest as of June 2022: -0.052x

Based on the latest financial reports, aap Implantate AG (AAQ1) has a cash flow conversion efficiency ratio of -0.052x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-659.50K ≈ $-771.02K USD) by net assets (€12.63 Million ≈ $14.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can aap Implantate AG fund operations to measure how many days the company can operate on defensive assets alone.

aap Implantate AG - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how aap Implantate AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

aap Implantate AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of aap Implantate AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Katana Capital Ltd AU:KAT	-0.013x
HWA AG F:H9W	-0.099x
Net Digital AG XETRA:VRL	-0.042x
Stakeholder Gold Corp V:SRC	-0.016x
Ascendis Health Ltd JSE:ASC	-0.011x
MKDWELL Tech Inc. Ordinary Share NASDAQ:MKDW	-0.119x
TP ICAP Group PLC LSE:TCAP	0.097x
Symphony Life Bhd KLSE:1538	-0.004x

Annual Cash Flow Conversion Efficiency for aap Implantate AG (2016–2024)

The table below shows the annual cash flow conversion efficiency of aap Implantate AG from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see AAQ1 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€10.46 Million ≈ $12.23 Million	€-1.12 Million ≈ $-1.31 Million	-0.107x	+70.14%
2023-12-31	€8.10 Million ≈ $9.47 Million	€-2.92 Million ≈ $-3.41 Million	-0.360x	-143.82%
2022-12-31	€12.83 Million ≈ $15.00 Million	€-1.89 Million ≈ $-2.21 Million	-0.148x	+23.67%
2021-12-31	€12.78 Million ≈ $14.94 Million	€-2.47 Million ≈ $-2.89 Million	-0.193x	+45.86%
2020-12-31	€10.29 Million ≈ $12.03 Million	€-3.67 Million ≈ $-4.30 Million	-0.357x	-16.83%
2019-12-31	€18.87 Million ≈ $22.06 Million	€-5.77 Million ≈ $-6.74 Million	-0.306x	-80.31%
2018-12-31	€34.92 Million ≈ $40.82 Million	€-5.92 Million ≈ $-6.92 Million	-0.170x	-32.90%
2017-12-31	€42.56 Million ≈ $49.76 Million	€-5.43 Million ≈ $-6.35 Million	-0.128x	+3.01%
2016-12-31	€54.78 Million ≈ $64.04 Million	€-7.20 Million ≈ $-8.42 Million	-0.131x	--

About aap Implantate AG

F:AAQ1 Germany Medical Devices

Market Cap

$30.63 Million

€26.20 Million EUR

Market Cap Rank

#23754 Global

#2076 in Germany

Share Price

€1.78

Change (1 day)

+0.56%

52-Week Range

€1.27 - €2.22

All Time High

€21.70